We are live on ! Find out more
LBPH

Longboard Pharmaceuticals, Inc. Common Stock
LBPH

Delisted

LBPH was delisted on the 29th of November, 2024.

Back to rankings

0 hedge funds and large institutions have $0 invested in Longboard Pharmaceuticals, Inc. Common Stock in 2024 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 124 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 125 → 0 (-125)

100% less funds holding in top 10

Funds holding in top 10: 4 → 0 (-4)

100% less capital invested

Capital invested by funds: $1.33B → $0 (-$1.33B)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 124

Holders
–
Holders Change
-125
Holders Change %
-100%
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
-4
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
124
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
-$145M
2
FCM
Farallon Capital Management
California
-$105M
3
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$97M
4
BlackRock
BlackRock
New York
-$94.6M
5
CAM
Cormorant Asset Management
Massachusetts
-$93M
Name Holding Trade Value Shares
Change 		Change in
Stake
Millennium Management
51
Millennium Management
New York
– -$1.85M -55,644 Closed
UBS AM
52
UBS AM
Illinois
– -$1.84M -55,079 Closed
Two Sigma Investments
53
Two Sigma Investments
New York
– -$1.82M -54,735 Closed
State of Wisconsin Investment Board
54
State of Wisconsin Investment Board
Wisconsin
– -$1.55M -46,522 Closed
RhumbLine Advisers
55
RhumbLine Advisers
Massachusetts
– -$1.42M -42,714 Closed
UOC
56
UBS O'Connor
Illinois
– -$1.31M -39,260 Closed
UBS Group
57
UBS Group
Switzerland
– -$1.24M -37,303 Closed
JF
58
Jump Financial
Illinois
– -$1.16M -34,800 Closed
AllianceBernstein
59
AllianceBernstein
Tennessee
– -$1.12M -33,680 Closed
Legal & General Group
60
Legal & General Group
United Kingdom
– -$1.12M -33,477 Closed
SVCM
61
Saturn V Capital Management
Texas
– -$1.05M -31,529 Closed
California State Teachers Retirement System (CalSTRS)
62
California State Teachers Retirement System (CalSTRS)
California
– -$1.04M -31,195 Closed
Citigroup
63
Citigroup
New York
– -$1.02M -30,466 Closed
Bank of America
64
Bank of America
North Carolina
– -$975K -29,255 Closed
Jane Street
65
Jane Street
New York
– -$950K -28,497 Closed
AA
66
ALPS Advisors
Colorado
– -$884K -26,532 Closed
TI
67
Trexquant Investment
Connecticut
– -$843K -25,305 Closed
Ameriprise
68
Ameriprise
Minnesota
– -$736K -22,073 Closed
MIM
69
MetLife Investment Management
New Jersey
– -$633K -18,980 Closed
Tudor Investment Corp
70
Tudor Investment Corp
Connecticut
– -$631K -18,925 Closed
Mirae Asset Global ETFs Holdings
71
Mirae Asset Global ETFs Holdings
Hong Kong
– -$590K -17,712 Closed
CF
72
Corebridge Financial
Texas
– -$576K -17,293 Closed
JGC
73
J. Goldman & Co
New York
– -$565K -16,962 Closed
SEI Investments
74
SEI Investments
Pennsylvania
– -$554K -16,631 Closed
Victory Capital Management
75
Victory Capital Management
Texas
– -$526K -15,773 Closed
1 2
3
4 5

LBPH Hedge Fund Activity: Q4 2024 in Review

0 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in Longboard Pharmaceuticals, Inc. Common Stock (LBPH) for Q4 2024, worth a combined $0 — down 100% from $1.33B a quarter earlier.

Sellers outnumbered buyers: 124 funds closed out of LBPH and 0 opened new positions — a net loss of 124 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Fidelity Investments, exiting entirely with an estimated $145M sold.

  • 0 institutional investors held Longboard Pharmaceuticals, Inc. Common Stock (LBPH) as of Q4 2024, down from 125 in Q3 2024.
  • Funds reported $0 of Longboard Pharmaceuticals, Inc. Common Stock stock for Q4 2024, down 100% quarter-over-quarter.
  • 0 funds opened new Longboard Pharmaceuticals, Inc. Common Stock positions in Q4 2024 and 124 closed out, a net change of -124 holders.
  • The largest Longboard Pharmaceuticals, Inc. Common Stock seller in Q4 2024 was Fidelity Investments, an estimated $145M sold.

Based on aggregated 13F filings for Q4 2024.